Single-Cycle Induction Chemotherapy Selects Patients With Advanced Laryngeal Cancer for Combined Chemoradiation: A New Treatment Paradigm
Susan G. Urba(University of Michigan), Jeremy M. G. Taylor(RAND Corporation), Mark E. Prince(University of Michigan), Carol R. Bradford(The Ohio State University), Norman D. Hogikyan(Michigan Medicine), Gregory T. Wolf(University of Michigan), Douglas B. Chepeha(University of Michigan), Julia Lee(University of Michigan), Francis P. Worden(Georgetown University), Theodoros N. Teknos(University Hospitals Seidman Cancer Center), Avraham Eisbruch(University of Michigan–Ann Arbor)
Cited by 267
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Validation of an instrument to measure voice-related quality of life (V-RQOL)
|Journal of Voice|1999|1.1k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
|Journal of Clinical Oncology|2017|653